INTRODUCTION Analyze the clinical

tumors are a rare entity and require wider resection margins (4cm), stabilization with prolene,mesh reinforcement and reconstruction with an appropriate muscle flap (Fig.A), with acceptable postoperative morbidity and mortality.

Histologically proven malignant tumors of chest wall and localized breast cancers with bone involvement. Exclusion Criteria: excisional biopsies of chest wall, primary tumors of spine and pancoast tumors of lung. Data noted: age, gender, histopathological type, resection margins, stabilization and reconstruction technique including type of flap used and the postoperative complications.

outcome of malignant chest wall tumors after excision treated with a single reconstruction method. Observational study from Jan 2010 to Oct 2018 (9 years) in the departments of Thoracic Surgery at Military Hospitals

PRIMARY MALIGNANT CHEST WALL TUMORSOutcome analysis of 86 patients

RESULTS The study included 86 patients;

An observational study by Prof Farhan Majeed, HOD Surgery CIMS/CMH Multan

CONCLUSION Malignant chest wall

Reference Journal of the College of Physicians and Surgeons Pakistan 2021, Vol. 31(07): 833-836

61 (70.9%) males and 25 (29.1%) females.Age ranging from 18-77 years with a mean of 47.84 ± 12.9 years.Palpable mass was the most common symptom occurring in 61 (70.9%) patients (Table.1). 21 (24.4%) had breast tumor with chest wall invasion.In the remaining 65 cases, most common histological type was chondrosarcoma occurring in 13 (15.1%) patients, followed by Ewing sarcoma in 12 (14%)(Table 3). Muscle flaps used and complications are as in table 2 and the following graph.

METHODOLOGY Inclusion Criteria:

Table 3: HISTOPATHOLOGY

Acco

unt

for

65% Ewing sarcoma

Chondrosarcoma

Desmoid tumour 1Malignant fibrohistocytoma 1Malignant Hemangiopericytoma 1Squamous cell 1GISTNeuroendocrineSyringomaPapillary carcinomaMalignant neural sheathDermatofibrosarcoma protuberansGiant cell tumourAdenocarcinomaAneurysmal cyst malignantRhabdomyosarcomaDermatofibrosarcomaPlasma cell Osteosarcoma

Acco

unt

for

35%

Transfusion -38 (48%)

Operative Technique and ResultFig. A

Patients

9(10.5%)

57(66.3%)

Omental flap

Pectoralis major muscle flap

Serratus anterior muscle flap

Latissimus dorsi fasciocutane-ous flap

Latissimus dorsi muscle flapMuscle flap used

9(10.5%)

9(10.5%)

2 (2.5%)

Perioperative Complications

Thoracotomy Neuralgia -25 (29%)

Seroma -16 (19%)

Pneumonia -9 (10%)

Surgical Site Infection -5

Pneumothorax -4

Ventilatory Support -2

Hemothorax -1

Table 2:

Chest pain

Palpable Mass

Fungating Mass

20

61

05

Table. 1: Symptoms

11122233334571213

1

6

42

5

3

7 8